{"transactions":[{"id":1114859,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T20:01:14.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":2.95,"value":5900.0,"ownership":{"direct":true},"balance_after":9305,"source":{"system":"sec-edgar","filing":"0001104659-25-058521","document":"tm2517636-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925058521/tm2517636-1_4seq1.xml","form_type":"4"}},{"id":1459846,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:17:22.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":29600,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001104659-24-077835","document":"tm2417696-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077835/tm2417696-4_4seq1.xml","form_type":"4"}},{"id":1731161,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:24:29.000Z","date":"2023-11-20","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed solely to reverse the previously reported purchase on the original form 4 filed on November 21, 2023 (the \"Original Form 4\"). Such purchase was rescinded by the registrant and the reporting person on November 22, 2023."}],"balance_after":7305,"source":{"system":"sec-edgar","filing":"0001104659-23-120765","document":"tm2331305-12_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120765/tm2331305-12_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1732549,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T19:33:45.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":824,"price":6.07,"value":5001.68,"ownership":{"direct":true},"balance_after":8129,"source":{"system":"sec-edgar","filing":"0001104659-23-120305","document":"tm2331305d6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120305/tm2331305d6_4seq1.xml","form_type":"4"}},{"id":1921739,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T01:05:04.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":476,"price":12.61,"value":6002.36,"ownership":{"direct":true},"balance_after":7305,"source":{"system":"sec-edgar","filing":"0001104659-23-044203","document":"tm2312464-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044203/tm2312464-2_4seq1.xml","form_type":"4"}},{"id":2049599,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:39:35.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":5967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":5967,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":5967},"source":{"system":"sec-edgar","filing":"0001104659-23-005477","document":"tm234043-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005477/tm234043-3_4seq1.xml","form_type":"4"}},{"id":2443823,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:42:52.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001104659-22-001642","document":"tm221949-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001642/tm221949-4_4seq1.xml","form_type":"4"}},{"id":2593516,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-08-23T15:36:48.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":500,"price":37.61,"value":18805.0,"ownership":{"direct":true},"balance_after":6829,"source":{"system":"sec-edgar","filing":"0001104659-21-108434","document":"tm2125684d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921108434/tm2125684d1_4seq1.xml","form_type":"4"}},{"id":2637011,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-09T22:27:57.000Z","date":"2021-07-07","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date."}],"balance_after":4000,"derivative":{"exercise_price":102.85,"expiration_date":"2031-07-07","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-21-090744","document":"tm2121908-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921090744/tm2121908-4_4seq1.xml","form_type":"4"}}]}